# Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer.

> **NCT05331833** · — · COMPLETED · sponsor: **Jianguo Sun** · enrollment: 90 (actual)

## Conditions studied

- Stage III Non-small-cell Lung Cancer

## Interventions

- **RADIATION:** The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.

## Key facts

- **NCT ID:** NCT05331833
- **Lead sponsor:** Jianguo Sun
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05331833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05331833, "Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05331833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*